Comparative Effectiveness Research Needs to Consider Optimal Dosing and Scheduling

J Clin Oncol. 2021 Jan 20;39(3):253-254. doi: 10.1200/JCO.20.02355. Epub 2020 Dec 17.

Authors

Andrew D Seidman¹, Elisa de Stanchina¹, Larry Norton¹, Aki Morikawa¹

Affiliation

¹ Andrew D. Seidman, MD, Elisa de Stanchina, PhD, and Larry Norton, MD, Memorial Sloan Kettering Cancer Center, New York, NY and Aki Morikawa, MD, University of Michigan, Ann Arbor, MI.

PMID: 33332193
DOI: 10.1200/JCO.20.02355

No abstract available

Publication types

Letter
Comment

MeSH terms

Comparative Effectiveness Research*
Drug Administration Schedule
Humans